Table 3 Univariate and multivariate cox proportional hazards analysis for all-cause mortality
Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age (year) | 1.062 (1.045–1.080) | < 0.001 | 1.049 (1.030.0010–1.069) | < 0.001 |
Gender (Male) | 0.581 (0.391–0.864) | 0.007 | ||
History of stroke/TIA | 4.263 (2.149–8.457) | < 0.001 | 2.398 (1.148–5.009) | 0.020 |
History of DM | 1.690 (1.138–2.510) | 0.009 | ||
History of CAD | 1.695 (1.162–2.473) | 0.053 | ||
History of HT | 1.538 (0.995–2.377) | 0.006 | ||
IRA | 0.987 (0.823–1.183) | 0.888 | ||
Multi-vessel disease | 2.001 (1.372–2.915) | < 0.001 | ||
Killip ≥2 | 3.619 (2.228–5.180) | < 0.001 | 2.791 (1.597–4.876) | < 0.001 |
LVEF (%) | 0.957 (0.938–0.977) | < 0.001 | 0.966 (0.945–0.989) | 0.003 |
Hemoglobin (g/dl) | 0.832 (0.763–0.907) | < 0.001 | ||
ΔMPV (fL) | 1.428 (1.210–1.685) | < 0.001 | 1.301 (1.070–1.582) | 0.008 |
Serum creatinine (mg/dl) | 1.235 (1.091–1.397) | 0.001 | ||
Statin usage at discharge | 0.413 (0.275–0.619) | < 0.001 | ||
Beta-blocker usage at discharge | 0.496 (0.326–0.756) | 0.001 | ||
ACE/ARB usage at discharge | 0.239 (0.118–0.484) | < 0.001 | ||